BMP and TGFβ use and release in bone regeneration

Turk J Med Sci. 2020 Nov 3;50(SI-2):1707-1722. doi: 10.3906/sag-2003-127.

Abstract

A fracture that does not unite in nine months is defined as nonunion. Nonunion is common in fragmented fractures and large bone defects where vascularization is impaired. The distal third of the tibia, the scaphoid bone or the talus fractures are furthermore prone to nonunion. Open fractures and spinal fusion cases also need special monitoring for healing. Bone tissue regeneration can be attained by autografts, allografts, xenografts and synthetic materials, however their limited availability and the increased surgical time as well as the donor site morbidity of autograft use, and lower probability of success, increased costs and disease transmission and immunological reaction probability of allografts oblige us to find better solutions and new grafts to overcome the cons. A proper biomaterial for regeneration should be osteoinductive, osteoconductive, biocompatible and mechanically suitable. Cytokine therapy, where growth factors are introduced either exogenously or triggered endogenously, is one of the commonly used method in bone tissue engineering. Transforming growth factor β (TGFβ) superfamily, which can be divided structurally into two groups as bone morphogenetic proteins (BMPs), growth differentiation factors (GDFs) and TGFβ, activin, Nodal branch, Mullerian hormone, are known to be produced by osteoblasts and other bone cells and present already in bone matrix abundantly, to take roles in bone homeostasis. BMP family, as the biggest subfamily of TGFβ superfamily, is also reported to be the most effective growth factors in bone and development, which makes them one of the most popular cytokines used in bone regeneration. Complications depending on the excess use of growth factors, and pleiotropic functions of BMPs are however the main reasons of why they should be approached with care. In this review, the Smad dependent signaling pathways of TGFβ and BMP families and their relations and the applications in preclinical and clinical studies will be briefly summarized.

Keywords: BMP; TGFß; bone regeneration; cytokine; release; signaling.

Publication types

  • Review

MeSH terms

  • Animals
  • Bone Morphogenetic Proteins* / metabolism
  • Bone Morphogenetic Proteins* / pharmacology
  • Bone Morphogenetic Proteins* / therapeutic use
  • Bone Regeneration* / drug effects
  • Bone Regeneration* / physiology
  • Fractures, Bone
  • Humans
  • Mice
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Transforming Growth Factor beta* / metabolism
  • Transforming Growth Factor beta* / pharmacology
  • Transforming Growth Factor beta* / therapeutic use

Substances

  • Bone Morphogenetic Proteins
  • Transforming Growth Factor beta